Table 4. Cardiovascular disease risk outcomes by higher and lower aerobic fitness groups. Mean ± standard deviation.
|
Peak oxygen uptake
(mL·kg-0.61.min-1) |
Peak oxygen uptake
(mL·FFM-1.min-1) |
| Lower |
Higher |
Lower |
Higher |
| BMI (kg·m-2) |
17.8 ± 2.9 (n=48) |
16.8 ± 1.6 (n=48) |
17.4 ± 2.38 (n=43) |
17.1 ± 2.43 (n=53) |
| TBF% |
19.5 ± 9.6 (n=43) |
16.2 ± 6.7 (n=43) |
16.2 ± 8.7 (n=43) |
19.6 ± 7.8 (n=43) |
| VAT (cm3) |
131.1 ± 86.4 (n=42) |
109.8 ± 63.6 (n=44) |
118.0 ± 60.2 (n=38) |
121.9 ± 86.9 (n=48) |
| Total cholesterol (mmol·L-1) |
4.57 ± 0.66 (n=38) |
4.45 ± 0.73 (n=41) |
4.39 ± 0.63 (n=37) |
4.61 ± 0.74 (n=42) |
| HDL-C (mmol·L-1) |
1.86 ± 0.44 (n=38) |
1.86 ± 0.41 (n=40) |
1.79 ± 0.40 (n=37) |
1.92 ± 0.44 (n=41) |
| LDL-C (mmol·L-1) |
2.34 ± 0.59 (n=38) |
2.24 ± 0.60 (n=40) |
2.24 ± 0.55 (n=37) |
2.33 ± 0.63 (n=41) |
| TG (mmol·L-1) |
0.81 ± 0.31 (n=38) |
0.79 ± 0.28 (n=40) |
0.78 ± 0.32 (n=37) |
0.81 ± 0.28 (n=41) |
| Glucose (mmol.L-1) |
4.38 ± 0.33 (n=38) |
4.29 ± 0.42 (n=42) |
4.37 ± 0.38 (n=37) |
4.30 ± 0.39 (n=43) |
| Specific insulin (pmol·L-1) |
45.1 ± 24.3 (n=35) |
51.0 ± 25.7 (n=34) |
43.4 ± 21.9 (n=36) |
53.1 ± 27.5 (n=33) |
| β-cell function (%) |
118.1 ± 44.7 (n=35) |
130.4 ± 47.5 (n=34) |
113.2 ± 35.2 (n=36) |
136.2 ± 53.8 (n=33) |
| HOMA-IS (%) |
153.7 ± 98.9 (n=35) |
127.0 ± 71.9 (n=34) |
157.3 ± 101.3 (n=36) |
122.4 ± 65.0 (n=33) |
| HOMA-IR |
0.92 ± 0.49 (n=35) |
1.04 ± 0.51 (n=34) |
0.89 ± 0.45 (n=36) |
1.07 ± 0.55 (n=33) |
Sample size (n=) is provided for each outcome. BMI - body mass index; TBF% - total body fat percentage; VAT - visceral adipose tissue; HDL-C - high density lipoprotein cholesterol; LDL-C – low density lipoprotein cholesterol; TG -Triglyceride; HOMA – Homeostatic model assessment; IS – Insulin sensitivity; IR – Insulin resistance. TBF% was entered as a covariate for the specific insulin, β-cell function, HOMA-IS and HOMA-IR outcomes.
